Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment. [PDF]
Front OncolMavaei M +7 more
europepmc +1 more source
Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translation. [PDF]
Cancer Biol TherWu Z +5 more
europepmc +1 more source
Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations. [PDF]
Mol BiomedSilvestri R +4 more
europepmc +1 more source
Development of Z<sub>HPV16E7</sub>- granzyme B immunoaffitoxin: dual mechanisms targeting hpv16-positive cervical cancer through epithelial-mesenchymal transition inhibition and cell death. [PDF]
Front ImmunolTan X +8 more
europepmc +1 more source
Shiga Toxin: Emerging Producer Strains, Prophylactic Approaches, and Application in Cancer Therapy. [PDF]
J Cancer PrevBabolhavaeji K +2 more
europepmc +1 more source
Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate. [PDF]
J VirolPincus SH +9 more
europepmc +1 more source
Targeted depletion of dysfunctional hematopoietic stem cells mitigates myeloid-biased differentiation in aged mice. [PDF]
Cell DiscovRen X, Wang Y, Zhang Y.
europepmc +1 more source
Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy-A Narrative Review. [PDF]
J Clin MedKędzierska M, Bańkosz M.
europepmc +1 more source